BOLT - Bolt Biotherapeutics, Inc.

Across the last three months, Bolt Biotherapeutics, Inc.'s insiders have reduced their positions by a net 38,584 shares worth roughly $128K.

Classified under Biotechnology (Health Care sector), BOLT's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Gujrathi Sheila	85.8K	-	-
CEO	Quinn William P.	25.4K	$82.2K	-
COO	Yonehiro Grant	17.3K	$55.9K	-
VP	Nemec Sarah	17.1K	$55.3K	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 16, 2024	Quinn William P.	President, CEO and CFO	Buy	5,000	$0.57	$2,834.75	+14.8%	-20.8%	-47.4%
Dec 12, 2023	Quinn William P.	Chief Financial Officer	Buy	11,829	$0.95	$11,240.96	+48.4%	+28.6%	-43.6%
Nov 30, 2023	Engleman Edgar60	Director	Sell	148,884	$0.87	$128,993.42	-37.2%	+39.5%	-24.9%
Nov 21, 2023	Vivo Capital Viii, LLC57	10% Owner	Sell	3,400	$0.90	$3,060.00	-3.0%	+32.9%	-34.1%
Nov 21, 2023	Engleman Edgar60	Director	Sell	1,943	$0.90	$1,751.42	-0.7%	+32.9%	-34.1%
Nov 20, 2023	Vivo Capital Viii, LLC57	10% Owner	Sell	86,054	$0.93	$79,933.22	-43.2%	+25.7%	-38.7%
Nov 20, 2023	Engleman Edgar60	Director	Sell	49,173	$0.93	$45,675.45	-15.4%	+25.7%	-38.7%
Jul 13, 2022	Novo Holdings A/s57	10% Owner	Sell	800,000	$2.00	$1,600,000.00	-17.8%	-41.9%	-43.5%
Dec 8, 2021	Quinn William P.	Chief Financial Officer	Buy	6,256	$7.04	$44,067.05	+45.0%	-37.3%	-70.8%
Dec 6, 2021	Perez Edith A.	Chief Medical Officer	Buy	1,328	$12.93	$17,175.09	New	-34.3%	-70.0%